Exelixis Inventory Turnover Ratio 2006-2019 | EXEL

Current and historical inventory turnover ratio for Exelixis (EXEL) from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Exelixis inventory turnover ratio for the three months ending September 30, 2019 was 0.56.
Exelixis Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.351B $0.854B
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ? (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.045B 16.02
CSL (CSLLY) Australia $87.810B 0.00
Gilead Sciences (GILD) United States $85.752B 10.62
Vertex Pharmaceuticals (VRTX) United States $56.573B 57.74
Biogen (BIIB) United States $52.731B 9.05
Illumina (ILMN) United States $47.124B 51.71
Regeneron Pharmaceuticals (REGN) United States $41.011B 17.96
Alexion Pharmaceuticals (ALXN) United States $24.231B 11.97
Incyte (INCY) United States $20.448B 47.47
Seattle Genetics (SGEN) United States $19.082B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.149B 0.00
Genmab (GNMSF) Denmark $14.038B 62.00
Alnylam Pharmaceuticals (ALNY) United States $13.244B 0.00
Galapagos (GLPG) Belgium $11.786B 30.37
Exact Sciences (EXAS) United States $11.058B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.267B 49.28
QIAGEN (QGEN) Netherlands $9.336B 30.44
BeiGene (BGNE) Cayman Islands $8.641B 0.00
Bio-Techne Corp (TECH) United States $8.220B 55.02
Amarin (AMRN) Ireland $8.148B 0.00
Sarepta Therapeutics (SRPT) United States $7.562B 0.00
BioNTech SE (BNTX) Germany $7.082B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.933B 0.00
Medicines (MDCO) United States $6.702B 0.00
Guardant Health (GH) United States $6.647B 0.00
Moderna (MRNA) United States $6.215B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.041B 15.36
Reata Pharmaceuticals (RETA) United States $6.040B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.961B 0.00
Bluebird Bio (BLUE) United States $4.812B 0.00
Repligen (RGEN) United States $4.725B 85.63
Ascendis Pharma (ASND) Denmark $4.637B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.380B 0.00
Spark Therapeutics (ONCE) United States $4.273B 0.00
Mirati Therapeutics (MRTX) United States $4.170B 0.00
Immunomedics (IMMU) United States $4.008B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.907B 0.00
Adaptive Biotechnologies (ADPT) United States $3.770B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.624B 0.00
Blueprint Medicines (BPMC) United States $3.582B 0.00
Alkermes (ALKS) Ireland $3.297B 0.00
MyoKardia (MYOK) United States $3.045B 0.00
Genmab (GMAB) Denmark $2.956B 6.09
UniQure (QURE) Netherlands $2.854B 0.00
Emergent Biosolutions (EBS) United States $2.753B 27.34
Halozyme Therapeutics (HALO) United States $2.746B 0.00
NeoGenomics (NEO) United States $2.741B 145.83
Acceleron Pharma (XLRN) United States $2.616B 0.00
Zai Lab (ZLAB) China $2.435B 0.00
Amicus Therapeutics (FOLD) United States $2.409B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.367B 0.00
Arena Pharmaceuticals (ARNA) United States $2.350B 5.47
RA PHARMCTL INC (RARX) United States $2.231B 0.00
Insmed (INSM) United States $2.038B 0.00
Ligand Pharmaceuticals (LGND) United States $1.830B 35.21
Myriad Genetics (MYGN) United States $1.827B 26.99
Dicerna Pharmaceuticals (DRNA) United States $1.788B 0.00
Akcea Therapeutics (AKCA) United States $1.763B 0.00
Denali Therapeutics (DNLI) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.663B 0.00
Epizyme (EPZM) United States $1.648B 0.00
Principia Biopharma (PRNB) United States $1.614B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.556B 0.00
Editas Medicine (EDIT) United States $1.518B 0.00
REGENXBIO (RGNX) United States $1.490B 0.00
Arvinas (ARVN) United States $1.446B 0.00
Fate Therapeutics (FATE) United States $1.412B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.387B 0.00
Innoviva (INVA) United States $1.353B 3.99
Athenex (ATNX) United States $1.342B 0.00
Alector (ALEC) United States $1.317B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
WAVE Life Sciences (WVE) Singapore $1.225B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.079B 0.00
Pharming Group (PHGUF) Netherlands $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.002B 0.00
Zealand Pharma (ZEAL) Denmark $0.986B 0.00
Codexis (CDXS) United States $0.912B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.889B 7.48
ZIOPHARM Oncology Inc (ZIOP) United States $0.876B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.867B 0.00
Twist Bioscience (TWST) United States $0.855B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.824B 0.00
Intellia Therapeutics (NTLA) United States $0.806B 0.00
Vericel (VCEL) United States $0.797B 297.33
MiMedx (MDXG) United States $0.783B 0.00
Anika Therapeutics (ANIK) United States $0.774B 25.12
Heska (HSKA) United States $0.745B 190.26
DBV Technologies S.A (DBVT) France $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.735B 0.00
ANI Pharmaceuticals (ANIP) United States $0.731B 12.47
UROGEN PHARMA (URGN) United States $0.707B 0.00
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
Sorrento Therapeutics (SRNE) United States $0.684B 0.00
Intra-Cellular Therapies (ITCI) United States $0.671B 0.00
Cellectis S.A (CLLS) France $0.669B 0.00
Cara Therapeutics (CARA) United States $0.654B 0.00
Mesoblast (MESO) Australia $0.650B 0.00
Kadmon Holdings (KDMN) United States $0.646B 0.00
Clovis Oncology (CLVS) United States $0.642B 0.00
GENFIT S.A (GNFT) France $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Retrophin (RTRX) United States $0.579B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.33
BioDelivery Sciences (BDSI) United States $0.569B 0.00
PHARMA MAR SA (PHMMF) Spain $0.569B 0.00
Cytokineticsorporated (CYTK) United States $0.562B 0.00
Dynavax Technologies (DVAX) United States $0.554B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.550B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.537B 3.71
Agenus (AGEN) United States $0.533B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Precision BioSciences (DTIL) United States $0.499B 0.00
Prothena (PRTA) Ireland $0.499B 0.00
Stemline Therapeutics (STML) United States $0.488B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Gritstone Oncology (GRTS) United States $0.416B 0.00
AnaptysBio (ANAB) United States $0.412B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.404B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
PDL BioPharma (PDLI) United States $0.397B 9.94
Bellus Health (BLU) Canada $0.387B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.373B 0.00
OSMOTICA PHARM (OSMT) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.346B 0.00
Pfenex (PFNX) United States $0.340B 0.00
Puma Biotechnology (PBYI) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.320B 0.00
Starpharma Holdings (SPHRY) Australia $0.311B 0.00
Kindred Biosciences (KIN) United States $0.310B 0.00
Kamada (KMDA) Israel $0.304B 8.87
CytomX Therapeutics (CTMX) United States $0.301B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.298B 0.00
Compugen (CGEN) Israel $0.298B 0.00
Scholar Rock Holding (SRRK) United States $0.297B 0.00
Geron (GERN) United States $0.294B 0.00
Cue Biopharma (CUE) United States $0.292B 0.00
Seres Therapeutics (MCRB) United States $0.286B 0.00
Senesco Technologies (ELOX) United States $0.280B 0.00
MannKind (MNKD) United States $0.279B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.269B 0.00
Inovio Pharmaceuticals (INO) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Exicure (XCUR) United States $0.241B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.238B 0.00
ChromaDex (CDXC) United States $0.238B 0.00
IVERIC Bio (ISEE) United States $0.235B 0.00
Theratechnologies (THTX) Canada $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.229B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.218B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
XOMA (XOMA) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Athersys (ATHX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.197B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.194B 0.00
Protagonist Therapeutics (PTGX) United States $0.193B 0.00
NantKwest (NK) United States $0.189B 0.00
Mersana Therapeutics (MRSN) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.185B 5.06
ARAVIVE, INC (ARAV) United States $0.184B 0.00
Cerecor (CERC) United States $0.184B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Five Prime Therapeutics (FPRX) United States $0.164B 0.00
Alcobra (ARCT) United States $0.164B 0.00
VBI Vaccines (VBIV) United States $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Dyadic (DYAI) United States $0.157B 0.00
Windtree Therapeutics (WINT) United States $0.148B 0.00
Aptinyx (APTX) United States $0.141B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.140B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.137B 0.00
Arsanis (XFOR) United States $0.137B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
TELA Bio (TELA) United States $0.130B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Novavax (NVAX) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Celyad SA (CYAD) Belgium $0.107B 0.00
Verastem (VSTM) United States $0.107B 0.00
BioTime (LCTX) United States $0.105B 5.39
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Strongbridge Biopharma (SBBP) United States $0.097B 2.59
Aduro Biotech (ADRO) United States $0.094B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
Synlogic (SYBX) United States $0.091B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
OvaScience (MLND) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.078B 0.00
Liquidia Technologies (LQDA) United States $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Curis (CRIS) United States $0.052B 0.00
Applied Genetic Technologies (AGTC) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Alimera Sciences (ALIM) United States $0.047B 0.00
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Checkpoint Therapeutics (CKPT) United States $0.045B 0.00
Orgenesis (ORGS) United States $0.043B 2.78
Vascular Biogenics (VBLT) Israel $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
AIT Therapeutics (XAIR) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Apricus Biosciences (SEEL) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Novogen (KZIA) Australia $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00